Acute Lymphoblastic Leukemia News and Research

RSS
Acute lymphoblastic leukemia (ALL) is a cancer of the white blood cells, the cells in the body that normally fight infections. There are two main types of white blood cells-lymphoid cells and myeloid cells. ALL affects lymphoid cells.
Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

St. Jude Hospital announces availability of largest collections of leukemia samples

St. Jude Hospital announces availability of largest collections of leukemia samples

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Why patients with ALL relapse after CAR-T cell therapy

Why patients with ALL relapse after CAR-T cell therapy

Why patients with ALL relapse after CAR-T cell therapy

Why patients with ALL relapse after CAR-T cell therapy

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Lower clinical trial enrollment associated with relapse risk in AYA leukemia patients

Lower clinical trial enrollment associated with relapse risk in AYA leukemia patients

Study: Children with acute lymphoblastic leukemia are immunologically disparate at birth

Study: Children with acute lymphoblastic leukemia are immunologically disparate at birth

New system accelerates discovery of chemical compounds that inhibit enzyme implicated in cancers

New system accelerates discovery of chemical compounds that inhibit enzyme implicated in cancers

Research shows new way to target drug delivery for brain tumors

Research shows new way to target drug delivery for brain tumors

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Engineering immune cells to develop promising cancer treatment

Engineering immune cells to develop promising cancer treatment

New personalized cellular therapy approved for use in the European Union

New personalized cellular therapy approved for use in the European Union

Study reveals how socioeconomic status affects racial, ethnic disparities in childhood cancer survival

Study reveals how socioeconomic status affects racial, ethnic disparities in childhood cancer survival

Rutgers researcher receives $100,000 grant to explore T-cell acute lymphoblastic leukemia

Rutgers researcher receives $100,000 grant to explore T-cell acute lymphoblastic leukemia

'Hijacked' cell response to stress reveals potential therapeutic targets for leukemia

'Hijacked' cell response to stress reveals potential therapeutic targets for leukemia

Researchers unravel how ALL invades the central nervous system

Researchers unravel how ALL invades the central nervous system

Staggering prices slow insurers’ coverage of CAR-T cancer therapy

Staggering prices slow insurers’ coverage of CAR-T cancer therapy

Scientists engineer bi-specific antibodies that attract immune killers directly to cancer cells

Scientists engineer bi-specific antibodies that attract immune killers directly to cancer cells

Study reveals rate of vertebral and non-vertebral fractures in children with leukemia

Study reveals rate of vertebral and non-vertebral fractures in children with leukemia